- Home
- TRML vs SDST Comparison
TRML vs SDST Comparison
Compare TRML & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- SDST
- Stock Information
- Founded
- TRML 2021
- SDST 2022
- Country
- TRML United States
- SDST United States
- Employees
- TRML N/A
- SDST N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- TRML Health Care
- SDST Finance
- Exchange
- TRML Nasdaq
- SDST Nasdaq
- Market Cap
- TRML 419.1M
- SDST 364.3M
- IPO Year
- TRML N/A
- SDST N/A
- Fundamental
- Price
- TRML $27.66
- SDST $7.28
- Analyst Decision
- TRML Strong Buy
- SDST
- Analyst Count
- TRML 3
- SDST 0
- Target Price
- TRML $64.67
- SDST N/A
- AVG Volume (30 Days)
- TRML 202.3K
- SDST 36.0K
- Earning Date
- TRML 11-07-2024
- SDST 11-13-2024
- Dividend Yield
- TRML N/A
- SDST N/A
- EPS Growth
- TRML N/A
- SDST N/A
- EPS
- TRML N/A
- SDST N/A
- Revenue
- TRML N/A
- SDST N/A
- Revenue This Year
- TRML N/A
- SDST N/A
- Revenue Next Year
- TRML N/A
- SDST N/A
- P/E Ratio
- TRML N/A
- SDST N/A
- Revenue Growth
- TRML N/A
- SDST N/A
- 52 Week Low
- TRML $12.12
- SDST $6.59
- 52 Week High
- TRML $48.31
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- TRML 58.78
- SDST N/A
- Support Level
- TRML $25.10
- SDST N/A
- Resistance Level
- TRML $28.35
- SDST N/A
- Average True Range (ATR)
- TRML 1.37
- SDST 0.00
- MACD
- TRML -0.26
- SDST 0.00
- Stochastic Oscillator
- TRML 57.98
- SDST 0.00
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is a development stage manufacturer of battery-grade lithium products deigned to supply the EV industry and helping to secure America's leadership in the energy transition. They enjoy a diversified supply of lithium from American brine sources.